Literature DB >> 12814731

Nosocomial infections in adult intensive-care units.

Jean-Louis Vincent1.   

Abstract

Nosocomial infections affect about 30% of patients in intensive-care units and are associated with substantial morbidity and mortality. Several risk factors have been identified, including the use of catheters and other invasive equipment, and certain groups of patients-eg, those with trauma or burns-are recognised as being more susceptible to nosocomial infection than others. Awareness of these factors and adherence to simple preventive measures, such as adequate hand hygiene, can limit the burden of disease. Management of nosocomial infection relies on adequate and appropriate antibiotic therapy, which should be selected after discussion with infectious-disease specialists and adapted as microbiological data become available.

Entities:  

Mesh:

Year:  2003        PMID: 12814731     DOI: 10.1016/S0140-6736(03)13644-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  144 in total

1.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

Review 2.  Antimicrobial resistance: a global multifaceted phenomenon.

Authors:  Francesca Prestinaci; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

3.  Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.

Authors:  Gabriel Cabot; Laura Zamorano; Bartolomé Moyà; Carlos Juan; Alfonso Navas; Jesús Blázquez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

4.  Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

Authors:  Pieter Depuydt; Dominique Benoit; Dirk Vogelaers; Geert Claeys; Gerda Verschraegen; Koenraad Vandewoude; Johan Decruyenaere; Stijn Blot
Journal:  Intensive Care Med       Date:  2006-09-16       Impact factor: 17.440

5.  Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.

Authors:  Hany Sahly; Yona Keisari; Erika Crouch; Nathan Sharon; Itzhak Ofek
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

6.  Contribution of the autolysin AtlA to the bactericidal activity of amoxicillin against Enterococcus faecalis JH2-2.

Authors:  Anne-Lise Bravetti; Stéphane Mesnage; Agnès Lefort; Françoise Chau; Catherine Eckert; Louis Garry; Michel Arthur; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

7.  In vivo detection of endotracheal tube biofilms in intubated critical care patients using catheter-based optical coherence tomography.

Authors:  Roshan Dsouza; Darold R Spillman; Ronit Barkalifa; Guillermo L Monroy; Eric J Chaney; Karen C White; Stephen A Boppart
Journal:  J Biophotonics       Date:  2019-01-22       Impact factor: 3.207

8.  A Bayesian decision-support system for diagnosing ventilator-associated pneumonia.

Authors:  Carolina A M Schurink; Stefan Visscher; Peter J F Lucas; Henk J van Leeuwen; Erik Buskens; Reinier G Hoff; Andy I M Hoepelman; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

Review 9.  The Collaborative Cross mouse model for dissecting genetic susceptibility to infectious diseases.

Authors:  Hanifa Abu Toamih Atamni; Aysar Nashef; Fuad A Iraqi
Journal:  Mamm Genome       Date:  2018-08-24       Impact factor: 2.957

10.  Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia.

Authors:  Patricia A Manderscheid; Ryan P Bodkin; Bruce A Davidson; Erik Jensen; Thomas A Russo; Paul R Knight
Journal:  Clin Diagn Lab Immunol       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.